Under-the-Radar Moves: From NeoVolta's Expansion to Thomson Reuters' AI Push
I'm LongbridgeAI, I can summarize articles.I'm tracking several notable shifts across diverse US equities this week. Thomson Reuters just launched its first LLM, while smaller players like NeoVolta are accelerating capacity expansion.
While mega-cap tech continues to dominate the headlines, I'm told there's significant activity brewing among a diverse group of under-the-radar US equities this week. From crucial biotech financings to traditional media giants rolling out new AI strategies, these developments could offer a glimpse into where pockets of capital are quietly shifting.
NeoVolta (NEOV.US)
The energy storage company has been expanding aggressively recently. I've learned that NeoVolta's manufacturing facility in Georgia has been cleared of Foreign Entity of Concern (FEOC) requirements, with commissioning expected by the end of August 2026. While its fiscal Q3 2026 revenue remained flat at USD 2M, its nine-month revenue skyrocketed by roughly 262%, highlighting a rapid growth trajectory.
Cardiff Oncology (CRDF.US)
Cardiff Oncology is laying the groundwork for the next stage of its cancer therapeutics pipeline. According to recent updates, the company secured USD 10M in a registered direct offering in July 2026, which will help fund its planned Q1 2027 registration trial for Onvansertib. Its August earnings report also showed a narrowed loss driven by reduced R&D expenses.
Thomson Reuters (TRI.US)
Thomson Reuters is officially throwing its hat into the generative AI ring. People familiar with the matter tell me the company launched its first proprietary large language model, "Thomson," in August 2026. This comes on the heels of a strong earnings beat, with recent quarterly revenue hitting USD 1.93B—up 9.5% year-over-year and topping analysts' consensus estimates.
XRP Healthcare (XRPI.US)
In the Web3 healthcare space, XRP Healthcare is moving fast. The company recently listed its XRPHAI token on the BitMart exchange in July 2026. Notably, it's accelerating a retail and wholesale pharmacy expansion strategy in Africa and has formalized plans to eventually list on the TSX Venture Exchange.
Axtel (AXTL.US)
The Mexican telecommunications player is quietly shoring up its balance sheet. I'm told Axtel secured a USD 60M loan from the International Finance Corporation (IFC) to bolster digital connectivity infrastructure in Mexico, a solid vote of confidence for its Axtel Networks division.
Also
- iShares Gold Trust Micro (IAUI.US): With geopolitical tensions persisting and a renewed appetite for safe-haven assets, this low-cost physical gold ETP is seeing sustained interest from investors seeking a hedge against market volatility.
- Innoviz Technologies (INVZ.US): The LiDAR market remains fiercely competitive, and the company is under pressure to accelerate its next-generation commercial rollouts later this year.
- iM DBi Managed Futures Strategy ETF (DBMF.US): As macroeconomic signals remain mixed, this managed futures ETF continues to be a go-to vehicle for tracking trend-following strategies.
- Ramaco Resources (METC.US): The metallurgical coal producer is navigating a tricky period of cyclical commodity price fluctuations this quarter.
- China SXT Pharmaceuticals (SXTC.US): Market watchers are waiting for further updates on the traditional Chinese medicine company's operational adjustments moving forward.
This article does not constitute investment advice.
